The authors warned that without a strategic plan for the "new normal of life with COVID, […] more people in the US will unnecessarily experience morbidity and mortality, health inequities will widen, and trillions will be lost from the US economy".
"The goal for the 'new normal' with COVID-19 does not include eradication or elimination, eg, the 'zero COVID' strategy. Neither COVID-19 vaccination nor infection appear to confer lifelong immunity. Current vaccines do not offer sterilising immunity against SARS-CoV-2 infection. Infectious diseases cannot be eradicated when there is limited long-term immunity following infection or vaccination or nonhuman reservoirs of infection", the doctors argued.
"Once an acceptable, yet suboptimal, testing infrastructure was established, it was marginalised, thought to be superfluous because of the vaccines. Even now, testing results are not reliably linked with sociodemographic data, vaccination status, or clinical outcomes; the availability of reliable rapid tests remains limited; and prices are too high", the ex-advisers said.
"It appears that SARS-CoV-2 will persist, and the COVID-19 pandemic will continue for some time. Consequently, to achieve a sustainable 'new normal' with substantially lower virus transmission and mortality from COVID-19, testing, surveillance, masking, and ventilation all need significant improvement", the doctors claimed.